Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy

被引：2
|
作者：
Yalta, Kenan [1 ]
Yetkin, Erta [1 ]
机构：
[1] Trakya Univ, Sch Med, Cardiol Dept, Edirne, Turkey
来源：
CJC OPEN | 2022年 / 4卷 / 09期
关键词：
D O I：
10.1016/j.cjco.2022.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [1] Reply to Yalta and YetkindCardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
    Duffett, Stephen A.
    Paulin, Frederic L.
    CJC OPEN, 2022, 4 (09) : 825 - 826
  • [2] Indications for implantable Cardioverter-Defibrillator
    Tebbenjohanns, J
    Niehaus, M
    Korte, T
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (41) : 2120 - 2124
  • [3] Indications for Pacemakers, Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Devices
    Samii, Soraya M.
    MEDICAL CLINICS OF NORTH AMERICA, 2015, 99 (04) : 795 - +
  • [4] Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
    Schuller, Joseph L.
    Zipse, Matthew
    Crawford, Thomas
    Bogun, Frank
    Beshai, John
    Patel, Amit R.
    Sweiss, Nadera J.
    Nguyen, Duy T.
    Aleong, Ryan G.
    Varosy, Paul D.
    Weinberger, Howard D.
    Sauer, William H.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (09) : 925 - 929
  • [5] Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator
    Daubert, J. Claude
    Leclercq, Christophe
    Mabo, Philippe
    EUROPACE, 2009, 11 : 87 - 92
  • [6] SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC SARCOIDOSIS
    Higgins, Angela
    Annapureddy, Amarnath
    Wang, Yongfei
    Minges, Karl
    Lampert, Rachel
    Rosenfeld, Lynda
    Jacoby, Daniel
    Curtis, Jeptha
    Miller, Edward
    Freeman, James
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 306 - 306
  • [7] Implantable cardioverter-defibrillator: Present and future indications
    Block, M
    Scheld, H
    Breithardt, G
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1996, 89 : 141 - 147
  • [8] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [9] ADVANCES IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY
    RAITT, MH
    BARDY, GH
    CURRENT OPINION IN CARDIOLOGY, 1994, 9 (01) : 23 - 29
  • [10] Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter-defibrillator implantation
    Ahmed, Raheel
    Jamil, Yumna
    Ramphul, Kamleshun
    Mactaggart, Sebastian
    Bilal, Maham
    Singh Dulay, Mansimran
    Shi, Rui
    Azzu, Alessia
    Okafor, Joseph
    Memon, Rahat A.
    Sakthivel, Hemamalini
    Khattar, Rajdeep
    Wells, Athol Umfrey
    Baksi, John Arun
    Wechalekar, Kshama
    Kouranos, Vasilis
    Chahal, Anwar
    Sharma, Rakesh
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2024,
12345